Canadian Cancer Society logo

Non-Hodgkin lymphoma

You are here: 

Non-Hodgkin lymphoma statistics

To provide the most current cancer statistics, researchers use statistical methods to estimate the number of new cancer cases and deaths until actual data become available.

Incidence and mortality

Incidence is the total number of new cases of cancer. Mortality is the number of deaths due to cancer.

It is estimated that in 2015:

  • 8,200 Canadians will be diagnosed with non-Hodgkin lymphoma.
  • 2,700 Canadians will die from non-Hodgkin lymphoma.
  • 4,500 men will be diagnosed with non-Hodgkin lymphoma and 1,450 will die from it.
  • 3,700 women will be diagnosed with non-Hodgkin lymphoma and 1,200 will die from it.

Chances (probability) of developing or dying from non-Hodgkin lymphoma

Based on 2010 estimates:

  • About 1 in 43 Canadian men is expected to develop non-Hodgkin lymphoma during his lifetime and 1 in 99 will die from it.
  • About 1 in 50 Canadian women is expected to develop non-Hodgkin lymphoma during her lifetime and 1 in 118 will die from it.

For more information about cancer statistics, go to Canadian Cancer Statistics publication.

Stories

Researchers Dr John White and Dr James Gleason Dr John White is developing a new 2-in-1 cancer treatment to outsmart drug resistance.

Learn more

Clinical trial discovery improves quality of life

Illustration of test tubes

A clinical trial led by the Society’s NCIC Clinical Trials group found that men with prostate cancer who are treated with intermittent courses of hormone therapy live as long as those receiving continuous therapy.

Learn more